FDA starts review of Roche’s multiple sclerosis pill
Source ↗
👁 0
💬 0
The FDA previously hadn’t ever accepted an application of a drug like fenebrutinib in two major forms of MS. But safety questions still hang over Roche’s program.
Comments (0)